The Future of Early Cancer Detection is Coming
Quantgene Serenity™ is the first early detection system that enables your physician to screen for multiple forms of cancer from just one blood draw.
Serenity combines precision sequencing with artificial intelligence to detect very small traces of cancer-related mutations in the blood. This is a new way to screen for cancer using cell-free DNA (cfDNA) from a simple blood draw.
Serenity has been studied in one of the largest cell-free-DNA trials and its laboratory process is undergoing CLIA approval for clinical use.
Expert physician support is at the core of Serenity. From answering questions to interpreting your results, Serenity is by your side.
The Future of Early Cancer Detection is Coming
Quantgene Serenity™ is the first early detection system that enables your physician to screen for multiple forms of cancer from just one blood draw.
Serenity combines precision sequencing with artificial intelligence to detect very small traces of cancer-related mutations in the blood. This is a new way to screen for cancer using cell-free DNA (cfDNA) from a simple blood draw.
Serenity has been studied in one of the largest cell-free-DNA trials and its laboratory process is undergoing CLIA approval for clinical use.
Expert physician support is at the core of Serenity. From answering questions to interpreting your results, Serenity is by your side.